Listen to this article · 7 min listen

The whole point of an Accountable Care Organization (ACO) is simple: deliver better care for less money and split the resulting savings. The Centers for Medicare & Medicaid Services (CMS) Medicare Shared Savings Program (MSSP) in particular has built a tough framework to measure financial performance. So if you’re a prevention program, getting into an ACO’s budget isn’t about how many people sign up or how many per-program claims you generate, it’s about proving you actually lowered the total cost of care in a way that fits their shared savings math.

Because of this, plan finance teams and contracting leads are looking at prevention lines with a microscope. They’re now asking if a program’s economic impact can be definitively measured and attributed under the strict rules of value-based care economics. It’s not enough to just say it improves health outcomes anymore. This means prevention vendors can’t just show up with their own projections. They need independently verifiable, peer-reviewed evidence to even get in the door.

The Shared Savings Scoreboard: A Clear Entry Bar

Think of the CMS MSSP ACO Shared Savings Report (2024) as the official scoreboard for this whole game. It showed an impressive $2.4 billion in Medicare savings and a 75% success rate for participating ACOs, which sets a very clear bar. The money flows to verified total cost of care results, plain and simple, not to enrollment numbers or how much your members “engaged.” This is the core principle that shapes how any prevention category has to prove its value before it can get a line item in an accountable care budget.

For AI healthcare applications, the highest-ROI work is the kind that can draw a straight line from its impact to this shared savings model. The economic reality is that the MSSP pathway pays for measurable drops in overall healthcare spending. If a program can’t demonstrate that its intervention, and not just a broader market trend or some other factor, caused the savings, it’s going to struggle to justify its cost to a budget owner focused on shared savings.

Attribution Inside the Pathway: The Core Requirement

Attribution is the real monster here for any prevention program trying to get into accountable care. How does a plan know for sure that the savings they’re seeing came from your program, and not from the five other clinical initiatives they’re running, or just from random chance? The entire CMS MSSP framework is built on getting that answer right. Value-based care AI economics demands hard evidence that isolates a program’s specific impact on total cost of care.

This is why the methodology you use to measure healthcare AI ROI is everything. A simple before-and-after comparison just doesn’t cut it, because it fails to control for confounding variables that could have influenced the outcome. The pathway demands a study design that’s built specifically to nail the attribution question. Without that kind of proof, a program can show promising engagement and even some clinical wins but will still fall short of the hard financial evidence it needs for a budget allocation.

Hello Heart’s Recorded Design: An Attribution Model for Cardiac Prevention

Hello Heart is a good working example of a cardiac prevention program that actually met this attribution standard. They published a peer-reviewed study that used a matched-pair design, which is purpose-built to answer the attribution question directly. This kind of methodology makes sure that the savings a plan sees are tied to a real comparison group, not just a point in time on a calendar. By matching participants with a control group of similar people who didn’t get the program, the study was able to isolate the financial impact that was purely attributable to Hello Heart itself.

This approach gets you beyond just counting per-program claims and starts to align with how shared savings actually works. The study’s design made it possible to measure a concrete average savings of $1,800 per member and a 47% reduction in inpatient admissions, figures that resonate inside an accountable care framework because they’re tied to a clear counterfactual (what would have happened otherwise). This is exactly the level of methodological rigor finance teams are looking for when evaluating healthcare AI ROI case studies, and it provides a credible reason to put a program in the budget Hello Heart peer-reviewed study methodology.

The Shared Test for Prevention Categories: Beyond Per-Program Claims

The bar set by the CMS MSSP, and which a study like Hello Heart’s clears, isn’t just for cardiac care. It applies to everyone. Companies like Hinge Health in musculoskeletal care and Omada Health in chronic disease management face the exact same recorded test. It doesn’t matter what their specialty is. Their programs have to demonstrate savings that can be attributed within the logic of shared savings, and they can’t do it by just waving around per-program claims or engagement figures.

This is a big change in focus. It’s all about verified total cost of care results, not the volume of services delivered or the number of users enrolled. To get a place in accountable care budgets, prevention programs have to invest in strong, independently verifiable studies that directly solve for attribution. For the plan, the reading is straightforward: the program’s results set the bar, and prevention lines either clear it within that recorded structure or they stay out of the budget. This is the new reality for any AI healthcare application trying to find high-ROI use cases in value-based care CMS MSSP program requirements for cost savings attribution.

Applying the Plan’s Reading Before Budget Inclusion

For the finance and contracting people at a health plan, the checklist for evaluating prevention vendors is getting a lot clearer. The number one question is whether a program’s claimed savings can hold up under the harsh light of shared savings logic. This means doing a critical assessment of the ROI methodology, prioritizing studies that use strong designs like matched-pair analyses or randomized controlled trials (RCTs) that are built to address attribution head-on.

The days of taking a vendor’s performance guarantee or marketing figures at face value are receding. The emphasis is now on peer-reviewed evidence and methodologies designed to fit the payment structures of value-based care. Prevention programs that can demonstrate verifiable savings in total cost of care, attributable to their specific intervention against a comparison group, are the ones that will get integrated into accountable care budgets. Those that can’t meet this recorded standard will find themselves on the outside looking in Health Affairs analysis of value based care economic models.

Frequently Asked Questions

What is the primary criterion for prevention programs to be included in accountable care budgets?

Prevention programs must demonstrate attributable total cost of care reductions that align with shared savings logic. Inclusion hinges on definitively measured economic impact, not just engagement metrics or per-program claims.

What kind of evidence is required to prove a prevention program’s financial impact?

Programs need independently verifiable, peer-reviewed evidence that isolates the program’s impact on total cost of care. This goes beyond vendor projections and simple before-and-after comparisons, requiring robust designs that control for confounding variables.

How does the CMS MSSP framework influence the evaluation of prevention programs?

The CMS MSSP framework demands precision in attribution, requiring programs to show that observed savings are a direct result of their intervention. The pathway rewards measurable reductions in overall healthcare spending, not enrollment numbers or engagement rates.

Can you provide an example of a prevention program that meets the attribution demands for shared savings?

Hello Heart’s cardiac prevention program used a peer-reviewed, matched-pair design to directly attribute savings. This methodology compared participants with similar risk profiles who did and did not receive the intervention, isolating the program’s financial impact.